SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Balance Labs, Inc. – ‘10-Q’ for 3/31/20 – ‘EX-101.CAL’

On:  Monday, 7/6/20, at 3:52pm ET   ·   For:  3/31/20   ·   Accession #:  1493152-20-12630   ·   File #:  333-202959

Previous ‘10-Q’:  ‘10-Q’ on 11/14/19 for 9/30/19   ·   Next:  ‘10-Q’ on 8/11/20 for 6/30/20   ·   Latest:  ‘10-Q’ on 11/2/23 for 9/30/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/06/20  Balance Labs, Inc.                10-Q        3/31/20   46:2.6M                                   M2 Compliance/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    217K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     22K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     21K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     17K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     17K 
12: R1          Document and Entity Information                     HTML     44K 
13: R2          Condensed Consolidated Balance Sheets               HTML    130K 
14: R3          Condensed Consolidated Balance Sheets               HTML     40K 
                (Parenthetical)                                                  
15: R4          Condensed Consolidated Statement of Operations      HTML     84K 
                (Unaudited)                                                      
16: R5          Condensed Consolidated Statement of Changes in      HTML     40K 
                Stockholders' Deficit (Unaudited)                                
17: R6          Condensed Consolidated Statement of Cash Flows      HTML     88K 
                (Unaudited)                                                      
18: R7          Business Organization and Nature of Operations      HTML     22K 
19: R8          Going Concern                                       HTML     20K 
20: R9          Summary of Significant Accounting Policies          HTML     68K 
21: R10         Stockholders' Equity                                HTML     27K 
22: R11         Related Party Transactions                          HTML     32K 
23: R12         Commitments and Contingencies                       HTML     20K 
24: R13         Notes Payable                                       HTML     27K 
25: R14         Subsequent Transactions                             HTML     22K 
26: R15         Summary of Significant Accounting Policies          HTML    123K 
                (Policies)                                                       
27: R16         Summary of Significant Accounting Policies          HTML     56K 
                (Tables)                                                         
28: R17         Stockholders' Equity (Tables)                       HTML     23K 
29: R18         Going Concern (Details Narrative)                   HTML     22K 
30: R19         Summary of Significant Accounting Policies          HTML     56K 
                (Details Narrative)                                              
31: R20         Summary of Significant Accounting Policies -        HTML     18K 
                Schedule of Equity Method Investments (Details)                  
32: R21         Summary of Significant Accounting Policies -        HTML     18K 
                Schedule of Equity Method Investments (Details)                  
                (Parenthetical)                                                  
33: R22         Summary of Significant Accounting Policies -        HTML     27K 
                Schedule of Join Venture of Financial Information                
                (Details)                                                        
34: R23         Summary of Significant Accounting Policies -        HTML     26K 
                Schedule of Fair Value of Assets on Recurring                    
                Basis (Details)                                                  
35: R24         Summary of Significant Accounting Policies -        HTML     20K 
                Schedule of Reconciliation of Assets (Details)                   
36: R25         Summary of Significant Accounting Policies -        HTML     29K 
                Schedule of Property and Equipment (Details)                     
37: R26         Summary of Significant Accounting Policies -        HTML     20K 
                Schedule of Intangible Assets (Details)                          
38: R27         Stockholders' Equity (Details Narrative)            HTML     61K 
39: R28         Stockholders' Equity - Summary of Warrants          HTML     34K 
                Outstanding (Details)                                            
40: R29         Related Party Transactions (Details Narrative)      HTML    164K 
41: R30         Commitments and Contingencies (Details Narrative)   HTML     17K 
42: R31         Notes Payable (Details Narrative)                   HTML    178K 
43: R32         Subsequent Transactions (Details Narrative)         HTML     38K 
45: XML         IDEA XML File -- Filing Summary                      XML     76K 
44: EXCEL       IDEA Workbook of Financial Reports                  XLSX     55K 
 6: EX-101.INS  XBRL Instance -- blnc-20200331                       XML    643K 
 8: EX-101.CAL  XBRL Calculations -- blnc-20200331_cal               XML    106K 
 9: EX-101.DEF  XBRL Definitions -- blnc-20200331_def                XML    367K 
10: EX-101.LAB  XBRL Labels -- blnc-20200331_lab                     XML    594K 
11: EX-101.PRE  XBRL Presentations -- blnc-20200331_pre              XML    507K 
 7: EX-101.SCH  XBRL Schema -- blnc-20200331                         XSD     93K 
46: ZIP         XBRL Zipped Folder -- 0001493152-20-012630-xbrl      Zip     76K 


‘EX-101.CAL’   —   XBRL Calculations — blnc-20200331_cal


This Exhibit is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" standalone="no" encoding="windows-1252"?>
<!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.3c -->
<!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
<!-- Field: Doc-Info; Name: Source; Value: BLNC %2D 20200331 10Q Q1 DFN.xfr; Date: 2020%2D07%2D06T17:44:04Z -->
<!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://balancelabs.co/role/DocumentAndEntityInformation" xlink:href="blnc-20200331.xsd#DocumentAndEntityInformation" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/BalanceSheets" xlink:href="blnc-20200331.xsd#BalanceSheets" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/BalanceSheetsParenthetical" xlink:href="blnc-20200331.xsd#BalanceSheetsParenthetical" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/StatementOfOperations" xlink:href="blnc-20200331.xsd#StatementOfOperations" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/StatementOfChangesInStockholdersDeficit" xlink:href="blnc-20200331.xsd#StatementOfChangesInStockholdersDeficit" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/StatementOfCashFlows" xlink:href="blnc-20200331.xsd#StatementOfCashFlows" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/BusinessOrganizationAndNatureOfOperations" xlink:href="blnc-20200331.xsd#BusinessOrganizationAndNatureOfOperations" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/GoingConcern" xlink:href="blnc-20200331.xsd#GoingConcern" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies" xlink:href="blnc-20200331.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/StockholdersEquity" xlink:href="blnc-20200331.xsd#StockholdersEquity" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/RelatedPartyTransactions" xlink:href="blnc-20200331.xsd#RelatedPartyTransactions" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/CommitmentsAndContingencies" xlink:href="blnc-20200331.xsd#CommitmentsAndContingencies" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/NotesPayable" xlink:href="blnc-20200331.xsd#NotesPayable" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/SubsequentTransactions" xlink:href="blnc-20200331.xsd#SubsequentTransactions" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="blnc-20200331.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="blnc-20200331.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/StockholdersEquityTables" xlink:href="blnc-20200331.xsd#StockholdersEquityTables" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/GoingConcernDetailsNarrative" xlink:href="blnc-20200331.xsd#GoingConcernDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="blnc-20200331.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfEquityMethodInvestmentsDetails" xlink:href="blnc-20200331.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfEquityMethodInvestmentsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfEquityMethodInvestmentsDetailsParenthetical" xlink:href="blnc-20200331.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfEquityMethodInvestmentsDetailsParenthetical" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfJoinVentureOfFinancialInformationDetails" xlink:href="blnc-20200331.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfJoinVentureOfFinancialInformationDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueOfAssetsOnRecurringBasisDetails" xlink:href="blnc-20200331.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueOfAssetsOnRecurringBasisDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfReconciliationOfAssetsDetails" xlink:href="blnc-20200331.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfReconciliationOfAssetsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfPropertyAndEquipmentDetails" xlink:href="blnc-20200331.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfIntangibleAssetsDetails" xlink:href="blnc-20200331.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfIntangibleAssetsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/StockholdersEquityDetailsNarrative" xlink:href="blnc-20200331.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/StockholdersEquity-SummaryOfWarrantsOutstandingDetails" xlink:href="blnc-20200331.xsd#StockholdersEquity-SummaryOfWarrantsOutstandingDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="blnc-20200331.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="blnc-20200331.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/NotesPayableDetailsNarrative" xlink:href="blnc-20200331.xsd#NotesPayableDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://balancelabs.co/role/SubsequentTransactionsDetailsNarrative" xlink:href="blnc-20200331.xsd#SubsequentTransactionsDetailsNarrative" xlink:type="simple"/>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information"/>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromRelatedPartiesNoncurrent" xlink:label="loc_us-gaapDueFromRelatedPartiesNoncurrent"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapDueFromRelatedPartiesNoncurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue" xlink:label="loc_us-gaapInvestmentOwnedAtFairValue"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapInvestmentOwnedAtFairValue" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesCurrent"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="blnc-20200331.xsd#BLNC_ConvertibleNotesPayableRelatedPartyCurrent" xlink:label="loc_BLNCConvertibleNotesPayableRelatedPartyCurrent"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_BLNCConvertibleNotesPayableRelatedPartyCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:label="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent"/>
<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent"/>
<link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="blnc-20200331.xsd#BLNC_AccumulatedLossesOfUnconsolidatedInvesteesInExcessOfInvestment" xlink:label="loc_BLNCAccumulatedLossesOfUnconsolidatedInvesteesInExcessOfInvestment"/>
<link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_BLNCAccumulatedLossesOfUnconsolidatedInvesteesInExcessOfInvestment" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesNoncurrent"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="loc_us-gaapConvertibleLongTermNotesPayable"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDueToRelatedPartiesNoncurrent" xlink:to="loc_us-gaapConvertibleLongTermNotesPayable" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDueToRelatedPartiesNoncurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/StatementOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statement of Operations (Unaudited)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:label="loc_us-gaapRelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapRelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalariesAndWages" xlink:label="loc_us-gaapSalariesAndWages"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSalariesAndWages" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:label="loc_us-gaapDebtSecuritiesAvailableForSaleUnrealizedGainLoss"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapDebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/StatementOfChangesInStockholdersDeficit" xlink:title="00000005 - Statement - Condensed Consolidated Statement of Changes in Stockholders&apos; Deficit (Unaudited)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/StatementOfCashFlows" xlink:title="00000006 - Statement - Condensed Consolidated Statement of Cash Flows (Unaudited)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="blnc-20200331.xsd#BLNC_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss1" xlink:label="loc_BLNCEquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss1"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_BLNCEquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss1" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInDueToRelatedParties"/>
<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDueToRelatedParties" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments"/>
<link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="loc_us-gaapPaymentsToAcquireEquityMethodInvestments"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireEquityMethodInvestments" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt" xlink:label="loc_us-gaapProceedsFromShortTermDebt"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromShortTermDebt" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/BusinessOrganizationAndNatureOfOperations" xlink:title="00000007 - Disclosure - Business Organization and Nature of Operations"/>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/GoingConcern" xlink:title="00000008 - Disclosure - Going Concern"/>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - Summary of Significant Accounting Policies"/>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/StockholdersEquity" xlink:title="00000010 - Disclosure - Stockholders&apos; Equity"/>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/RelatedPartyTransactions" xlink:title="00000011 - Disclosure - Related Party Transactions"/>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/CommitmentsAndContingencies" xlink:title="00000012 - Disclosure - Commitments and Contingencies"/>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/NotesPayable" xlink:title="00000013 - Disclosure - Notes Payable"/>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/SubsequentTransactions" xlink:title="00000014 - Disclosure - Subsequent Transactions"/>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000015 - Disclosure - Summary of Significant Accounting Policies (Policies)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000016 - Disclosure - Summary of Significant Accounting Policies (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/StockholdersEquityTables" xlink:title="00000017 - Disclosure - Stockholders&apos; Equity (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/GoingConcernDetailsNarrative" xlink:title="00000018 - Disclosure - Going Concern (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000019 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfEquityMethodInvestmentsDetails" xlink:title="00000020 - Disclosure - Summary of Significant Accounting Policies - Schedule of Equity Method Investments (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfEquityMethodInvestmentsDetailsParenthetical" xlink:title="00000021 - Disclosure - Summary of Significant Accounting Policies - Schedule of Equity Method Investments (Details) (Parenthetical)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfJoinVentureOfFinancialInformationDetails" xlink:title="00000022 - Disclosure - Summary of Significant Accounting Policies - Schedule of Join Venture of Financial Information (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueOfAssetsOnRecurringBasisDetails" xlink:title="00000023 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value of Assets on Recurring Basis (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfReconciliationOfAssetsDetails" xlink:title="00000024 - Disclosure - Summary of Significant Accounting Policies - Schedule of Reconciliation of Assets (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000025 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property and Equipment (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/SummaryOfSignificantAccountingPolicies-ScheduleOfIntangibleAssetsDetails" xlink:title="00000026 - Disclosure - Summary of Significant Accounting Policies - Schedule of Intangible Assets (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedTrademarksGross" xlink:label="loc_us-gaapFiniteLivedTrademarksGross"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedTrademarksGross" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/StockholdersEquityDetailsNarrative" xlink:title="00000027 - Disclosure - Stockholders&apos; Equity (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/StockholdersEquity-SummaryOfWarrantsOutstandingDetails" xlink:title="00000028 - Disclosure - Stockholders&apos; Equity - Summary of Warrants Outstanding (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000029 - Disclosure - Related Party Transactions (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000030 - Disclosure - Commitments and Contingencies (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/NotesPayableDetailsNarrative" xlink:title="00000031 - Disclosure - Notes Payable (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://balancelabs.co/role/SubsequentTransactionsDetailsNarrative" xlink:title="00000032 - Disclosure - Subsequent Transactions (Details Narrative)"/>
</link:linkbase>

Top
Filing Submission 0001493152-20-012630   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 8, 11:44:14.1am ET